Integra LifeSciences Holdings (IART)

Days of sales outstanding (DSO)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Receivables turnover		5.91	5.73	5.72	6.62	5.76
DSO	days	61.79	63.68	63.83	55.16	63.39

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.91
= 61.79

The days of sales outstanding (DSO) for Integra LifeSciences Holdings have shown varying trends over the past five years. In December 2020, the DSO was 63.39 days, which decreased to 55.16 days by December 2021, indicating an improvement in the company's efficiency in collecting receivables. However, by December 2022, the DSO increased to 63.83 days, surpassing the previous year's level.

In the following years, there was a slight fluctuation in DSO, with values of 63.68 days in December 2023 and 61.79 days in December 2024. These fluctuations suggest some inconsistency in the company's ability to collect receivables promptly.

Overall, the DSO metrics show that Integra LifeSciences Holdings has made efforts to manage its receivables efficiently, as evidenced by the decrease in DSO in 2021. However, the subsequent fluctuations in DSO indicate the need for continued focus on optimizing the collection process to maintain healthy cash flows and working capital management.